This study explored the relationship between clotting activation and tissue plasminogen activator and its inhibitor in cirrhotic patients with different degrees of liver failure. Sixty-seven patients (40 men, 27 women; age = 31-77 yr) with cirrhosis diagnosed by liver biopsy were divided into three
Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis
β Scribed by Francesco Violi; Domenico Ferro; Stefania Basili; Claudio Quintarelli; Mirella Saliola; Cesare Alessandri; Corrado Cordova; Francesco Balsano
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 597 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
Sixty-one patients with different degrees of liver failure, 23 with Child-Pugh class B and 38 with Child-Pugh class C, were studied and observed for 3 yr. Coagulation index analysis showed significantly lower values of prothrombin activity, more prolonged activated partial thromboplastin time, higher bilirubin and fibrinogen degradation products values in class C patients. Among all patients, 28 had fibrinogen degradation products values greater than 10 kg/ml, and in these patients a hyperfibrinolytic state was confirmed by higher values of circulating plasminogen activator antigen (17.3 f 8.7 ng/ml vs. 5.41 f 1.9 ng/ml; p < 0.0001) and activity (6.6 f 2.1 IU/ml vs. 1.92 f 1.12 IU/ml; p < 0.0001) and significantly lower plasminogen activator inhibitor antigen (6.4 f 3.5 ng/ml vs. 15.8 f 5.6 ng/ml; p < 0.0001) and activity (3.6 f 2.2 IU/ml vs. 8.5 2 3.9 IU/ml; p < 0.0001). Patients with positive fibrinogen degradation products had higher serum bilirubin (6 +-4 mg/dl vs. 2 f 2 mg/dl; p < 0.0001) and lower fibrinogen (156 f 52 mg/dl vs. 194 f 62 mg/d& p < 0.02) than patients without hyperfibrinolysis. During the follow-up period, 41 patients died, 22 from fatal gastrointestinal hemorrhage and 19 from liver failure. Thirty patients experienced fatal (22 patients) and nonfatal (8 patients) gastrointestinal hemorrhage. Patients with positive fibrinogen degradation products or class C had a higher risk of gastrointestinal bleeding than patients with negative fibrinogen degradation products (odds ratio = 8) or class B (odds ratio = 3.5), respectively. Cox's multiple regression model showed that positive fibrinogen degradation products was the best bleeding predictor (p coefficient = 3.9 f 0.7 S.E.M., p < 0.001).
This study indicates that in cirrhosis the presence of hyperfibrinolysis should be regarded as an important warning sign of gastrointestinal bleeding. (HEPA- TOLOGY 1992;15:672-676.)
π SIMILAR VOLUMES
of the bleeding. In patients with serum creatinine level ΓΊ200 mmol/ L, doses were reduced to amoxicillin plus clavulanic acid (Augmentin, Beecham, Nanterre, France) 500 mg/100 kg twice daily and ciproflox-From the Unite Β΄de Soins Intensifs, Service d'He Β΄pato-Gastroente Β΄rologie, Ho Λpital Saintacin
of beta-blockers in the prevention of recurrent bleeding in A meta-analysis of 12 selected randomized trials was patients with cirrhosis and to assess the effect of this drug performed to assess the efficacy of beta-blockers in the on long-term survival by a new meta-analysis, including reprevention